Venus Concept Inc. (VERO)
$
2.68
+0.11 (4.10%)
Key metrics
Financial statements
Free cash flow per share
-20.6361
Market cap
5 Million
Price to sales ratio
0.1052
Debt to equity
10.9054
Current ratio
1.2807
Income quality
0.2926
Average inventory
17.6 Million
ROE
-10.7517
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The financial data pertains to the fiscal year 2024. The company recorded an operating income of -$27,184,000.00 reflecting its earnings from core operations. Additionally, the diluted EPS is -$66.28 accounting for potential share dilution. The company reported depreciation and amortization expenses of $3,889,000.00 reflecting the wear and tear of its assets. Furthermore, the cost of revenue for the company is $20,527,000.00 showcasing its production and operational expenses. Venus Concept Inc. develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, along with related services both in the United States and internationally. Its diverse product portfolio features aesthetic device platforms like Venus Legacy, a non-invasive device utilized in dermatological and surgical procedures; Venus Versa, a versatile device for various aesthetic and cosmetic treatments; and Venus Viva, an advanced portable fractional RF system for dermatological procedures focused on skin ablation and resurfacing. The stock is affordable at $2.68 making it suitable for budget-conscious investors. It has a high average trading volume of 2,510,041.00 indicating strong liquidity in the marketplace. With a market capitalization of $4,982,442.00 the company is classified as a small-cap player. As a key player in the Medical - Devices industry, Venus Concept Inc. contributes significantly to the overall market landscape and continues to innovate within the sector. Additionally, it belongs to the Healthcare sector, driving innovation and growth through its cutting-edge technologies. Among its offerings are Venus Fiore for treating various medical conditions, Venus Bliss for non-invasive body contouring, and NeoGraft, an automated hair restoration system. Venus Velocity and Venus Epileve assist in hair removal and the treatment of pseudofolliculitis barbae, while the ARTAS iX robotic system aids in hair follicle extraction and transplantation.
Is Venus Concept Inc. (VERO) a good investment?
Investing in Venus Concept Inc. (VERO) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
What is Venus Concept Inc. (VERO)'s stock forecast?
Analysts predict Venus Concept Inc. stock to fluctuate between $2.10 (low) and $14.50 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Venus Concept Inc.'s market capitalization?
As of 2025-07-07, Venus Concept Inc.'s market cap is $4,982,442, based on 1,859,120 outstanding shares.
How does Venus Concept Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Venus Concept Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Venus Concept Inc. (VERO) stock?
To buy Venus Concept Inc. (VERO) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for VERO. Place an order (Market, Limit, etc.).
What is the best time to invest in Venus Concept Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Venus Concept Inc. stock ever split?
Venus Concept Inc.'s last stock split was 1:11 on 2025-03-04.
How did Venus Concept Inc. perform in the last earnings report?
Revenue: $64,833,000 | EPS: -$66.28 | Growth: 869.01%.
Where can I find Venus Concept Inc.'s investor relations reports?
Visit https://www.venusconcept.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Venus Concept Inc.?
You can explore historical data from here
What is the all-time high and low for Venus Concept Inc. stock?
All-time high: $567.60 (2021-02-22) | All-time low: $2.10 (2025-05-16).
What are the key trends affecting Venus Concept Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a definitive agreement to sell its Venus Hair business to MHG Co. Ltd (“Meta Healthcare Group”) in an all-cash transaction valued at $20 million, subject to a customary working capital adjustment. The net proceeds from the transaction, once completed, will enhance the Company's balance sheet and financial condition and provide valuable capital to fund strategic growth initiatives.
seekingalpha.com
Venus Concept Inc. (NASDAQ:VERO ) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - CFO Conference Call Participants Thomas McGovern - Maxim Group Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2025 Earnings Conference Call for Venus Concept Inc. At this time all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
globenewswire.com
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, May 15, 2025.
seekingalpha.com
Venus Concept Inc. (NASDAQ:VERO ) Q4 2024 Earnings Conference Call March 31, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - EVP and CFO Conference Call Participants Marie Thibault - BTIG Jeremy Pearlman - Maxim Group Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
globenewswire.com
TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it will effect a 1-for-11 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split will be effective at 5:00 p.m. Eastern Standard Time on March 3, 2025. The Company's common stock is expected to begin trading on The Nasdaq Capital Market on a split-adjusted basis at the open of trading on March 4, 2025.
seekingalpha.com
Venus Concept Inc. (NASDAQ:VERO ) Q3 2024 Earnings Conference Call November 13, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Sam Eiber - BTIG Thomas McGovern - Maxim Group Operator Please standby. Good day, ladies and gentlemen, and welcome to the Third Quarter 2024 Earnings Conference Call for Venus Concept Incorporated.
globenewswire.com
TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2024.
globenewswire.com
Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets Enhances future international growth profile with new partners and regulatory certifications in key global aesthetic markets
globenewswire.com
TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, November 13, 2024.
globenewswire.com
Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date Second Substantial Reduction of Existing Debt by Madryn Asset Management in 2024; the Company has reduced its debt balance by 54% year-to-date
See all news
